Stay updated on ARO-C3 in Renal Disease Clinical Trial
Sign up to get notified when there's something new on the ARO-C3 in Renal Disease Clinical Trial page.

Latest updates to the ARO-C3 in Renal Disease Clinical Trial page
- Check6 days agoChange DetectedThe ARO-C3 clinical trial record is displayed, describing the completed Phase 1/2a study in healthy volunteers and patients with complement-mediated renal disease, including participation criteria, study locations, treatments, and measured outcomes.SummaryDifference53%

- Check13 days agoChange DetectedThe footer revision identifier changes from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check20 days agoChange DetectedA site-wide banner announces an NIH terminology transition and links to related updates and FAQs.SummaryDifference1%

- Check27 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check34 days agoChange DetectedThe site footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check55 days agoChange DetectedThe study page now shows a 403 Forbidden error, blocking access to the study record. This replaces the usual study details view with an error screen.SummaryDifference18%

Stay in the know with updates to ARO-C3 in Renal Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARO-C3 in Renal Disease Clinical Trial page.